Nurix Therapeutics (NRIX) Revenue & Revenue Breakdown
Nurix Therapeutics Revenue Highlights
Latest Revenue (Y)
$76.99M
Latest Revenue (Q)
$12.59M
Main Segment (Y)
Collaboration Revenue
Nurix Therapeutics Revenue by Period
Nurix Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-11-30 | $76.99M | 99.31% |
| 2022-11-30 | $38.63M | 29.84% |
| 2021-11-30 | $29.75M | 66.95% |
| 2020-11-30 | $17.82M | -42.73% |
| 2019-11-30 | $31.11M | -16.91% |
| 2018-11-30 | $37.45M | - |
Nurix Therapeutics generated $76.99M in revenue during NA 2023, up 99.31% compared to the previous quarter, and up 205.58% compared to the same period a year ago.
Nurix Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-08-31 | $12.59M | 4.10% |
| 2024-05-31 | $12.09M | -27.09% |
| 2024-02-29 | $16.59M | 9.41% |
| 2023-11-30 | $15.16M | -17.91% |
| 2023-08-31 | $18.47M | -39.80% |
| 2023-05-31 | $30.68M | 141.83% |
| 2023-02-28 | $12.69M | 87.01% |
| 2022-11-30 | $6.78M | -37.14% |
| 2022-08-31 | $10.79M | -5.61% |
| 2022-05-31 | $11.43M | 18.82% |
| 2022-02-28 | $9.62M | 30.08% |
| 2021-11-30 | $7.40M | -27.86% |
| 2021-08-31 | $10.25M | 44.58% |
| 2021-05-31 | $7.09M | 41.51% |
| 2021-02-28 | $5.01M | -25.09% |
| 2020-11-30 | $6.69M | 63.75% |
| 2020-08-31 | $4.08M | -2.32% |
| 2020-05-31 | $4.18M | 46.02% |
| 2020-02-29 | $2.86M | 53.81% |
| 2019-11-30 | $1.86M | -82.40% |
| 2019-08-31 | $10.58M | 12.09% |
| 2019-05-31 | $9.44M | 2.22% |
| 2019-02-28 | $9.23M | - |
Nurix Therapeutics generated $12.59M in revenue during Q3 2024, up 4.10% compared to the previous quarter, and up 41.04% compared to the same period a year ago.
Nurix Therapeutics Revenue Breakdown
Nurix Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Nov 23 |
|---|---|
| Collaboration Revenue | $56.99M |
| License Revenue | $20.00M |
Nurix Therapeutics's latest annual revenue breakdown by segment (product or service), as of Nov 23: Collaboration Revenue (74.02%), and License Revenue (25.98%).
Quarterly Revenue by Product
| Product/Service | Aug 24 | May 24 | Nov 23 | Aug 23 | May 23 |
|---|---|---|---|---|---|
| License Revenue | - | - | - | - | - |
| Collaboration Revenue | $12.59M | $12.09M | $27.84M | $18.47M | $10.68M |
Nurix Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Aug 24: Collaboration Revenue (100.00%).
Nurix Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| KYMR | Kymera Therapeutics | $78.59M | $3.74M |
| ARVN | Arvinas | $78.50M | $102.40M |
| NRIX | Nurix Therapeutics | $76.99M | $12.59M |
| FHTX | Foghorn Therapeutics | $34.16M | $6.89M |
| RLAY | Relay Therapeutics | $25.55M | - |
| STOK | Stoke Therapeutics | $8.78M | $4.22M |
| GBIO | Generation Bio | $5.90M | $4.06M |
| STTK | Shattuck Labs | $1.66M | $1.61M |
| PLRX | Pliant Therapeutics | $1.58M | - |
| LYEL | Lyell Immunopharma | $130.00K | $3.00K |
| BDTX | Black Diamond Therapeutics | - | - |
| CCCC | C4 Therapeutics | - | - |
| NKTX | Nkarta | - | - |
| ELYM | Eliem Therapeutics | - | - |
| PRLD | Prelude Therapeutics | - | - |
| SANA | Sana Bio | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
NRIX Revenue FAQ
What is Nurix Therapeutics’s yearly revenue?
Nurix Therapeutics's yearly revenue for 2023 was $76.99M, representing an increase of 99.31% compared to 2022. The company's yearly revenue for 2022 was $38.63M, representing an increase of 29.84% compared to 2021. NRIX's yearly revenue for 2021 was $29.75M, representing an increase of 66.95% compared to 2020.
What is Nurix Therapeutics’s quarterly revenue?
Nurix Therapeutics's quarterly revenue for Q3 2024 was $12.59M, a 4.10% increase from the previous quarter (Q2 2024), and a -31.84% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $12.09M, a -27.09% decrease from the previous quarter (Q1 2024), and a -60.58% decrease year-over-year (Q2 2023). NRIX's quarterly revenue for Q1 2024 was $16.58M, a 9.41% increase from the previous quarter (Q4 2023), and a 30.74% increase year-over-year (Q1 2023).
What is Nurix Therapeutics’s revenue growth rate?
Nurix Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 158.78%, and for the last 5 years (2019-2023) was 147.43%.
What are Nurix Therapeutics’s revenue streams?
Nurix Therapeutics's revenue streams in v 23 are Collaboration Revenue, and License Revenue. Collaboration Revenue generated $56.99M in revenue, accounting 74.02% of the company's total revenue License Revenue generated $20M in revenue, accounting 25.98% of the company's total revenue
What is Nurix Therapeutics’s main source of revenue?
For the fiscal year ending Nov 23, the largest source of revenue of Nurix Therapeutics was Collaboration Revenue. This segment made a revenue of $56.99M, representing 74.02% of the company's total revenue.